CBAY CymaBay Therapeutics Inc. Stock Forecast Period (n+15) 25 Feb 2021


Stock Forecast


As of Thu Feb 25 2021 00:00:03 GMT+0000 (Coordinated Universal Time) shares of CBAY CymaBay Therapeutics Inc. 4.14 percentage change in price since the previous day's close. Around 0 of 68887000 changed hand on the market. The Stock opened at 4.99 with high and low of 4.89 and 5.08 respectively. The price/earnings ratio is: - and earning per share is -0.94. The stock quoted a 52 week high and low of 1.21 and 9.06 respectively.

BOSTON (AI Forecast Terminal) Thu, Feb 25, '21 AI Forecast today took the forecast actions: In the context of stock price realization of CBAY CymaBay Therapeutics Inc. is a decision making process between multiple investors each of which controls a subset of design variables and seeks to minimize its cost function subject to future forecast constraints. That is, investors act like players in a game; they cooperate to achieve a set of overall goals.Machine Learning utilizes multiple learning algorithms to obtain better predictive powers. In our research, we utilize machine learning to combine the results from the Neural Network and Support Vector Machines. Machine Learning based technical analysis (n+15) for CBAY CymaBay Therapeutics Inc. as below:
Using machine learning modified The random walk index model RWI equivalent to a model of stock market dynamics with price expectations, we analyze the reaction of investors to speculations. Analyzing those data we were able to establish the amount by which each stock felt the speculative attacks, a dampening factor which expresses the capacity of a market of absorving a shock, and also a frequency related with volatility after the speculation. Using the correlation matrices, the speculative buffer for the shares of CBAY CymaBay Therapeutics Inc. as below:

CBAY CymaBay Therapeutics Inc. Credit Rating Overview


We rerate CBAY CymaBay Therapeutics Inc. because of derivatives receivables represent more than 3% of total assets for entities reporting under IFRS (or under local GAAP similar to IFRS for the accounting of derivatives) and are domiciled in countries for which our BICRA group is '1' to '4'. We use econometric methods for period (n+15) simulate with RRS Independent T-Test. Reference code is: 2010. Beta DRL value REG 36 Rational Demand Factor LD 6159.7998. In determining how prudent a company's risk management is, we look for evidence that management has historically anticipated potential company-specific or market-related setbacks and has taken necessary actions to ensure sufficient liquidity. Credit Rating AI Process rely on primary sources of information: Sec Filings, Financial Statements, Credit Ratings, Semantic Signals. Take a look at Machine Learning section for Financial Deep Reinforcement Learning.

Oscillators are used for generating credit risk signals by using the semantic and financial signals. The value of the oscillators indicate the strength of trend. Using the correlation matrices, the risk map for CBAY CymaBay Therapeutics Inc. as below:
Frequently Asked QuestionsQ: What is CBAY CymaBay Therapeutics Inc. stock symbol?
A: CBAY CymaBay Therapeutics Inc. stock referred as NASDAQ:CBAY
Q: What is CBAY CymaBay Therapeutics Inc. stock price?
A: On share of CBAY CymaBay Therapeutics Inc. stock can currently be purchased for approximately 5.03
Q: Do analysts recommend investors buy shares of CBAY CymaBay Therapeutics Inc. ?
A: Machine Learning utilizes multiple learning algorithms to obtain better predictive powers. In our research, we utilize machine learning to combine the results from the Neural Network and Support Vector Machines. View Machine Learning based technical analysis for CBAY CymaBay Therapeutics Inc. at daily forecast section
Q: What is the earning per share of CBAY CymaBay Therapeutics Inc. ?
A: The earning per share of CBAY CymaBay Therapeutics Inc. is -0.94
Q: What is the market capitalization of CBAY CymaBay Therapeutics Inc. ?
A: The market capitalization of CBAY CymaBay Therapeutics Inc. is 346501624
We work across the world

From London to San Francisco, to our home base in (Saint Helier) Jersey, we’re looking for extraordinary and creative scientists to help us drive the field forward.

Disclaimers: AC Investment Inc. currently does not act as an equities executing broker, credit rating agency or route orders containing equities securities. In our Machine Learning experiment, we focus on an approach known as Decision making using game theory. We apply principles from game theory to model the relationships between rating actions, news, market signals and decision making.The rating information provided is for informational, non-commercial purposes only, does not constitute investment advice and is subject to conditions available in our Legal Disclaimer. Usage as a credit rating or as a benchmark is not permitted.

77 Massachusetts Avenue Cambridge, MA 02139 617-253-1000 pr@ademcetinkaya.com